Skip to content

Use of thromboelastography to tailor antiplatelet therapy in patients undergoing Stent-assisted coiling Intracranial Aneurysm: A Medical Records Based Retrospective Study

Use of thromboelastography to tailor antiplatelet therapy in patients undergoing Stent-assisted coiling Intracranial Aneurysm: A Medical Records Based Retrospective Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033992
Enrollment
Unknown
Registered
2020-06-20
Start date
2020-06-30
Completion date
Unknown
Last updated
2020-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial aneurysm

Interventions

Adjustment group:Individualized antiplatelet medication plan selected according to TEG parameters
control group:Without antiplatelet medication

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Stent assisted embolization of intracranial aneurysms, including ruptured and unruptured aneurysms; 2. Patients with hunt Hess grading of 0-3 at admission; 3. Patients with complete peri-operative imaging and laboratory examination data; 4. Patients over 18 years old.

Exclusion criteria

Exclusion criteria: 1. Patients who were treated with drugs that affect coagulation function before admission; 2. Patients with severe cardiovascular disease or ischemic stroke; 3. Patients with serious liver and kidney dysfunction, malignant tumor, chronic inflammatory disease and obvious coagulation function abnormality at admission.

Design outcomes

Primary

MeasureTime frame
Thromboelastogram;Ischemic events during follow-up;Bleeding events during follow-up;

Countries

China

Contacts

Public ContactYuanshu Li

The First Affiliated Hospital of Chongqing Medical University

350139822@qq.com+86 13890876959

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026